With the continuous recognition of the molecular mechanisms underlying the regulation of ncRNAs by STAT3 and its impact on tumor occurrence and development, new targeted anticancer strategies based on STAT3 or ncRNAs are gradually being developed, which might also provide potential therapeutic targets for cancer [17]. The gene discussed is STAT3; the disease is neoplasm.